Division of Nephrology

New study uses genetic data to support use of thiazide diuretics for kidney stone prevention

A Vanderbilt University Medical Center genetic association study of more than 1 million adults supports the use of the common blood thinner medication thiazide diuretics for kidney stone prevention.

Kidney disease gene also has a protective mutation

African Americans have long been known to be at increased risk of kidney disease due to a dangerous genetic mutation that creates a hole in the kidney cells, but Vanderbilt researchers have now discovered a protective genetic mutation that covers the hole to eliminate the risk.

Nephrology society lauds Bock’s research on kidney development

Vanderbilt’s Fabian Bock, MD, PhD, won two awards at the Basic Research Forum for Emerging Kidney Scientists, presented virtually by the American Society of Nephrology and American Physiological Society.

Fissell receives Medal of Excellence from the American Association of Kidney Patients

Vanderbilt’s William Fissell, MD, recently received the 2022 Medal of Excellence Award in the physician category from the American Association of Kidney Patients.

Accelerating podocyte production

A new method developed by Vanderbilt researchers to generate kidney cells from stem cells offers a faster and less expensive way to make these valuable tools for studying kidney diseases.

Insulin in vials

New way to bEET insulin resistance

Signaling molecules called EETs could improve insulin resistance, a primary risk factor for Type 2 diabetes and cardiovascular disease, Vanderbilt researchers have discovered.

1 2